MMP9 and neoplasm: Notably, as we described above, since MDSCs (like TAMs) secrete MMP9 [35] to facilitate MMP9-dependent cleavage of PD-L1 surface expression anti-PD1 Ab resistance [36], hypoxia hinders the anti-tumor effects of anti-PD1 Abs.